Quality before scale
Conservative quality decisions and complete batch documentation come first. Volume can wait.
Private-label generic pharmaceuticals · Illinois, USA
Private-label generics, built on commercial experience.
Narova is an early-stage pharmaceutical company building a U.S. own-label portfolio of generic medicines. It draws on its founder’s experience in branded generics in India and is being set up from the start around U.S. regulatory requirements.
Overview
A focused company for value-driven generics
Narova is building toward an own-label model. In that model, an established contract manufacturer makes each product, Narova’s name goes on the label, and a licensed third-party logistics provider stores and ships it.
The labeler answers for everything the label stands for, so Narova is starting with the groundwork: the entity, the licensure path, and the right manufacturing and distribution counterparties.
Regulatory rigor
State and federal licensure comes before any distribution. Narova will name each licence on this site, with its issuing body and number, once it is granted.
Long-term partnerships
Narova aims for transparent terms and clear responsibilities with every application holder, manufacturer and logistics provider it works with.
Experience
Built on experience in branded generics
Before Narova, founder Kanan Singh was a partner in a branded-generics business in India. Its product catalogue included nine brands across six therapeutic areas, from acute care to long-term therapy, with a particular focus on maternal and women’s health.
- Brands in catalogue
- 9
- Therapeutic areas
- 6
- Dosage forms
- 3
Gastroenterology
Acid-related disorders, including ulcer, reflux and dyspepsia care.
Anti-infectives
Respiratory, urinary, gastrointestinal and mixed infections, in adult and paediatric forms.
Pain & inflammation
Musculoskeletal pain, sprains and inflammatory conditions.
Haematinics
Iron-deficiency anaemia, with a focus on pregnancy and lactation.
Bone health
Calcium and vitamin D therapy for osteoporosis and maternal needs.
Nutritional support
Micronutrient and antioxidant supplementation.
Dosage forms:
Tablets
Capsules
Dry syrups
These products were marketed in India under Indian regulation by a company in which the founder was a partner. They are not Narova products and are not offered in the United States.
Quality & Compliance
How Narova will operate
In pharmaceutical supply, a label is a promise about everything that happened before it. These are the standards Narova is being built to meet.
FDA-registered manufacturing
Narova will source only from FDA-registered contract manufacturers operating under current Good Manufacturing Practice.
Licensure first
Narova will hold the required state and federal licences, and FDA labeler registration, before any product is distributed.
Supply-chain traceability
Distribution will follow the Drug Supply Chain Security Act, which requires package-level tracing, through licensed third-party logistics providers.
Partnership integrity
Clear quality agreements, defined responsibilities and plain dealing with every counterparty.
The path to market
-
In progress
Company formation
Illinois limited liability company
-
Next
Licensure & registration
State licences and FDA labeler code
-
Planned
Manufacturing & logistics
Supply, quality and 3PL agreements
-
Planned
First products
Launch under the Narova label
Contact
Contact Narova
Narova welcomes conversations with NDA and ANDA holders, contract manufacturers, licensed third-party logistics providers, and regulatory and licensing consultants.